A therapeutic HPV16 E7 vaccine in combination with active anti-FGF-2 immunization synergistically elicits robust antitumor immunity in mice-Reference-Cited by-同舟云学术

A therapeutic HPV16 E7 vaccine in combination with active anti-FGF-2 immunization synergistically elicits robust antitumor immunity in mice

Published:2020-10 Issue: Volume:29 Page:102254
ISSN:1549-9634
Container-title:Nanomedicine: Nanotechnology, Biology and Medicine
language:en
Short-container-title:Nanomedicine: Nanotechnology, Biology and Medicine

Author:

Xie Hanghang,Shu Congyan,Bai Hongmei,Sun Pengyan,Liu Hongxian,Qi Jialong,Li Sijin,Ye Chao,Gao Fulan,Yuan Mingcui,Chen Yongjun,Pan Manchang,Yang Xu,Ma Yanbing

Publisher

Elsevier BV

Subject

Pharmaceutical Science,General Materials Science,Biomedical Engineering,Molecular Medicine,Medicine (miscellaneous),Bioengineering

Reference39 articles.

1. Global burden of human papillomavirus and related diseases;Forman;Vaccine,2012

2. Human papillomavirus types 16 and 18 vaccine (recombinant, AS04 adjuvanted, adsorbed) [Cervarix]: profile report;Keam;BioDrugs,2008

3. What is the evidence that tumors are angiogenesis dependent?;Folkman;J Natl Cancer Inst,1990

4. The role of angiogenesis in solid tumours: an overview;Makrilia;Eur J Intern Med,2009

5. Tumor angiogenesis: therapeutic implications;Folkman;N Engl J Med,1971

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Vitamin D3 (Calcitriol) Monotherapy Decreases Tumor Growth, Increases Survival, and Correlates with Low Neutrophil-to-Lymphocyte Ratio in a Murine HPV-16-Related Cancer Model;Biomedicines;2024-06-18

2. Antitumor Effects of Annopurpuricin A, an Acetogenin from the Roots of Annona purpurea;Revista Brasileira de Farmacognosia;2023-10-05

3. Engineered Norovirus-Derived Nanoparticles as a Plug-and-Play Cancer Vaccine Platform;ACS Nano;2023-02-13

4. Prognostic value of the RNA editing enzyme: ADAR1, and its association with immune cells infiltration in pancreatic adenocarcinoma;Genes & Diseases;2023-01

5. FGF signalling facilitates cervical cancer progression;The FEBS Journal;2022-01-03